BERNARD ADDOGOH: Open Payments
NPI 1841534120 · MIDDLETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 37 payments from 12 companies in 2025. Trend: 2023 $139 · 2024 $584 · 2025 $1,473
Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 7 | $262 |
| Neurocrine BioSciences, Inc. | 5 | $235 |
| HARMONY BIOSCIENCES LLC | 5 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $158 |
| Otsuka America Pharmaceutical, Inc. | 4 | $144 |
| Gilead Sciences, Inc. | 1 | $123 |
| Alkermes, Inc. | 3 | $122 |
| United Therapeutics Corporation | 2 | $120 |
| ABBVIE INC. | 3 | $71 |
| JAZZ PHARMACEUTICALS INC. | 1 | $33 |
Products named: PURIFIED CORTROPHIN GEL, INGREZZA, WAKIX, CAPLYTA, REXULTI, TYVASO, LYBALVI, VRAYLAR.
Industry payments across DE — which companies pay providers there.
